Big investors are treating music catalogs like gold mines, pouring billions into acquiring hit songs. This rush of capital is creating a rising tide that lifts companies with existing music rights portfolios.
Warner and Bain's massive joint venture isn't just another deal—it's validation that music IP is now a premium asset class. Companies in this collection are at the forefront of a major shift in how creative content is valued.
The stability of streaming revenues has transformed music catalogs from unpredictable assets into reliable income streams. This fundamental shift is driving valuation increases across the entire music rights ecosystem.
Market capitalisation summary and investor takeaways for the provided basket. Total and per-stock breakdown included.
WMG: $17.43B
SPOT: $141.09B
RSVR: $502.84M
Music rights are being recognized as a premium asset class by major investors. The Warner-Bain partnership signals a new era where companies that own, manage, or distribute music catalogs stand to benefit from rising valuations and increased transaction activity in the music IP space.
This collection includes music publishers, streaming services, radio companies, and asset managers with exposure to music rights. These companies are positioned to capture value from the growing trend of treating creative assets as financial investments with stable, long-term returns.
We've handpicked companies directly involved in the music rights business as well as those that benefit from adjacent growth. From major players like Warner Music Group to streaming platforms and radio networks, each company has strategic positioning in this evolving landscape.
Warner Music Group and Bain Capital have joined forces in a $1.2 billion venture to acquire iconic music catalogs. This collection features carefully selected companies positioned to benefit from the increasing value of music rights and the growing interest from institutional investors in this emerging asset class.
Published on July 2
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+5
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+22.29%
On average, analysts expect assets in this group to grow 22.29% over the next year.
12 of 15 assets in this group are rated Buy by professional analysts.
